Tien Christopher J, Astrahan Melvin A, Kim Jenna M, Materin Miguel, Chen Zhe, Nath Ravinder, Liu Wu
Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT.
Department of Radiation Oncology, University of Southern California Keck School of Medicine, Los Angeles, CA.
Brachytherapy. 2017 Sep-Oct;16(5):1057-1064. doi: 10.1016/j.brachy.2017.06.014. Epub 2017 Aug 1.
To quantify the dosimetric impact of incorporating patient-specific CT-based models rather than the conventional stylized-standard model for eye plaque brachytherapy planning.
Plaque Simulator was used to plan 16 patients using both CT-based patient-specific eye model and stylized-standard (SS) eye models. Plaque position was initially based on the SS model and compared against their patient-specific model without changing the plaque loading pattern and seed strength. Dosimetric parameters were compared for tumor and healthy ocular structures.
Patient-specific ocular parameters ranged from 0.40 to 1.38 of SS model values. If plaques were placed based on SS model eyelet positions, target volume receiving prescription dose (V) is overpredicted by 5.9% on average (max: 27%), and D is overpredicted by 17.2 Gy on average (max: 58.1 Gy). If the plaques were recentered, 13 of 16 patients had changes in V of less than 2%, whereas half of the patients still had optic disc dose difference greater than 5 Gy (max: 36.2 Gy). The largest differences were observed with a target-to-optic disk distance less than 6 mm. No substantial dose differences were observed for the tumor apex, fovea, lens, and opposing retina.
Patient-specific modeling is recommended for clinical planning, especially with target-to-optic disk distances less than 6 mm, due to significant differences compared with SS model.
量化在眼部敷贴近距离放射治疗计划中,采用基于患者特异性CT模型而非传统的标准化模型所产生的剂量学影响。
使用敷贴模拟器,分别基于基于CT的患者特异性眼部模型和标准化(SS)眼部模型,对16例患者进行计划。敷贴位置最初基于SS模型,并在不改变敷贴加载模式和粒子强度的情况下,与患者特异性模型进行比较。比较肿瘤和健康眼部结构的剂量学参数。
患者特异性眼部参数为SS模型值的0.40至1.38。如果根据SS模型的小孔位置放置敷贴,接受处方剂量(V)的靶体积平均高估5.9%(最大值:27%),D平均高估17.2 Gy(最大值:58.1 Gy)。如果重新调整敷贴中心,16例患者中有13例V的变化小于2%,而一半患者的视盘剂量差异仍大于5 Gy(最大值:36.2 Gy)。在靶区至视盘距离小于6 mm时观察到最大差异。在肿瘤顶端、黄斑、晶状体和对侧视网膜未观察到明显的剂量差异。
由于与SS模型相比存在显著差异,建议在临床计划中采用患者特异性建模,尤其是在靶区至视盘距离小于6 mm时。